Roche NimbleGen Income Statement
View: Annual
| Dec 06 | Dec 05 | Dec 04 | |
|---|---|---|---|
| Revenue | 13.5 | 9.5 | 4.5 |
| Cost of Goods Sold | 7.8 | 7.2 | 4.6 |
| Gross Profit | 5.7 | 2.3 | (0.1) |
| Gross Profit Margin | 42.4% | 24.5% | 0.0% |
| SG&A Expense | 12.5 | 7.6 | 8.1 |
| Depreciation & Amortization | -- | -- | -- |
| Operating Income | (6.7) | (5.3) | (8.2) |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | 0.4 | 0.1 | 0.0 |
| Nonoperating Expenses | 0.5 | 0.0 | 0.1 |
| Income Before Taxes | (6.8) | (5.2) | (8.3) |
| Income Taxes | 0.0 | 0.0 | 0.0 |
| Net Income After Taxes | (6.8) | (5.2) | (8.3) |
| Continuing Operations | (6.8) | (5.2) | (8.3) |
| Discontinued Operations | 0.0 | 0.0 | 0.0 |
| Total Operations | (6.8) | (5.2) | (8.3) |
| Total Net Income | (6.8) | (5.2) | (8.3) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | -- | -- | -- |
| Dividends per Share | -- | -- | -- |
